Production of pharmaceutical proteins by transgenic animals.
about
Characterization of bioactive recombinant human lysozyme expressed in milk of cloned transgenic cattleGeneration of Transgenic Porcine Fibroblast Cell Lines Using Nanomagnetic Gene Delivery Vectors.Glycan analysis of therapeutic glycoproteinsAvian embryos and related cell lines: A convenient platform for recombinant proteins and vaccine production.Recombinant human factor IX produced from transgenic porcine milk.Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis.Cre-LoxP-regulated expression of monoclonal antibodies driven by an ovalbumin promoter in primary oviduct cells.Transgenic mouse technology: principles and methodsVaccination of rabbits with an alkylated toxoid rapidly elicits potent neutralizing antibodies against botulinum neurotoxin serotype B.Could protein tertiary structure influence mammary transgene expression more than tissue specific codon usage?Human extracellular superoxide dismutase (EC-SOD) expression in transgenic chickenKnock-in of Enhanced Green Fluorescent Protein or/and Human Fibroblast Growth Factor 2 Gene into β-Casein Gene Locus in the Porcine Fibroblasts to Produce Therapeutic Protein.Stem cells in veterinary medicine.Epigenetic changes of lentiviral transgenes in porcine stem cells derived from embryonic origin.Plasma proteomic profiles of bovine growth hormone transgenic mice as they age.Large-Scale Purification of r28M: A Bispecific scFv Antibody Targeting Human Melanoma Produced in Transgenic Cattle.Targeting Human α-Lactalbumin Gene Insertion into the Goat β-Lactoglobulin Locus by TALEN-Mediated Homologous RecombinationAdeno-associated-virus-mediated transduction of the mammary gland enables sustained production of recombinant proteins in milk.In vitro meat production system: why and how?Assessing Tn5 and Sleeping Beauty for transpositional transgenesis by cytoplasmic injection into bovine and ovine zygotes.Oral immunotherapy for pollen allergy using T-cell epitope-containing egg white derived from genetically manipulated chickensUse of transgenic animals in biotechnology: prospects and problems.Ingestion of milk containing the Dp2 peptide, a dust mite allergen, protects mice from allergic airway inflammation and hyper-responsiveness.Transient Expression of Tetrameric Recombinant Human Butyrylcholinesterase in Nicotiana benthamiana.Characterization of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori).The use of lectin microarray for assessing glycosylation of therapeutic proteins.Comparison of Different Electroporation Parameters on Transfection Efficiency of Sheep Testicular Cells.Expression of recombinant human lysozyme in transgenic chicken promotes the growth of Bifidobacterium in the intestine and improves postnatal growth of chicken.Role of secretory immunoglobulin A and secretory component in the protection of mucosal surfaces.Chloroplast-derived vaccines against human diseases: achievements, challenges and scopes.Transduction of human recombinant proteins into mitochondria as a protein therapeutic approach for mitochondrial disorders.Therapeutic application of monoclonal antibodies in cancer: advances and challenges.Novel GM animal technologies and their governance.Expression of recombinant antibodies.Recent developments in therapeutic protein expression technologies in plants.The history of monoclonal antibody development - Progress, remaining challenges and future innovationsOviduct-specific enhanced green fluorescent protein expression in transgenic chickens.Cloning and Molecular Characterization of Porcine β-casein Gene (CNS2).The transgenic animal platform for biopharmaceutical production.Chlorella species as hosts for genetic engineering and expression of heterologous proteins: Progress, challenge and perspective.
P2860
Q21004096-FCE5BF5D-7CEA-4FA2-945D-7803350F494DQ27345423-FEF3B605-876F-4865-B149-4E23B9820FACQ28082842-0B0B886C-829F-4D2F-90B8-6F6E62F21E6BQ30234979-85A0F915-F35B-499C-8BBC-A9A2256E04E0Q33736142-E6D00156-25AC-4D3D-A98F-923D6778C692Q33780365-13B24E65-82C9-4E78-A14B-F2DE5C47E8AAQ33793459-7372AFB4-4EF0-4FE7-B700-ED1BEC04F75EQ33893351-2FE0D06D-9B3A-443C-98EF-35A1891EF934Q33909140-7D1553E2-D710-483D-ABF4-EEAE6A2A93FDQ33987983-D98889B3-F739-41AD-B82E-346F2669CAF1Q34049531-BCD996DD-8DB1-4629-A0E4-007153D2B290Q34424075-F418CAAA-A380-4E1B-B0BA-94A27F8F326BQ34971872-90826DC3-6A2D-4522-8486-C0E8696716E2Q34973614-B8C19117-0C4F-4AB4-B349-6F3F8CE29E66Q35223799-ED392B7E-7A0C-42F8-9CA9-BB5207E46D7AQ35808466-58BF788A-1C1E-4A57-BB0F-1E3B8AFA6538Q36039890-EAC9579E-39C9-495A-A0E8-22AEE6347F6AQ36158788-F05C6863-6212-433C-8303-1CB6CC506842Q36289736-AADC7A2E-866F-44D5-B3CD-C8326027D032Q36310808-5BF69983-E4E3-4A76-B311-E8A8919D3397Q36353886-D1F61094-AA7A-4652-9251-B2535615618AQ36730328-7C848D98-13DF-4A70-923E-ACF83160C1C2Q36946940-436591B1-0799-4CF9-A779-A765949857D3Q37009481-E6BDF423-B44E-434D-B7FF-4FAC895A8F76Q37138255-B482E5A7-9596-4AAA-9169-214E7E452576Q37138938-D47B5F5C-83BF-4DC8-B723-D23ECFF58F10Q37232036-A9AE5F7B-151A-4CFD-9E90-D50FF603AE64Q37405219-253B503E-1A6E-4B5C-8518-3B1DF3E6CAECQ37742184-5A4C63D6-A061-472C-8200-C29E745B3215Q37859086-10806884-C0C6-4959-8967-3B958C1D1148Q37923355-658594EF-D3A1-446D-94B6-74A64636BB1BQ38057179-46CACC10-6551-4987-8F83-EF84349A3525Q38115497-C4A088DD-496E-45DA-B9A1-CF6BBA119817Q38126016-8AA2EBA2-14D8-4FBD-BA45-394C4C83D844Q38261152-39DE463E-7209-4ECE-BE35-E073B00376A6Q38311132-335FFA90-C5FA-41F8-A9AF-FE4DD88B8B10Q38428139-AC8993DB-84D8-4309-B09B-7AF6B2BE271FQ38465155-F7878237-3BDA-4781-AD0E-4E0609BC253AQ38714835-8703FA0E-3056-410C-95A5-FD183BE45300Q38837138-079C3F24-AD5C-4046-AB73-AA5F4EF48FCB
P2860
Production of pharmaceutical proteins by transgenic animals.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Production of pharmaceutical proteins by transgenic animals.
@ast
Production of pharmaceutical proteins by transgenic animals.
@en
Production of pharmaceutical proteins by transgenic animals.
@nl
type
label
Production of pharmaceutical proteins by transgenic animals.
@ast
Production of pharmaceutical proteins by transgenic animals.
@en
Production of pharmaceutical proteins by transgenic animals.
@nl
prefLabel
Production of pharmaceutical proteins by transgenic animals.
@ast
Production of pharmaceutical proteins by transgenic animals.
@en
Production of pharmaceutical proteins by transgenic animals.
@nl
P1476
Production of pharmaceutical proteins by transgenic animals.
@en
P2093
Louis-Marie Houdebine
P304
P356
10.1016/J.CIMID.2007.11.005
P577
2008-02-19T00:00:00Z